US 12,264,177 B2
Neuroactive steroids and their methods of use
Maria Jesus Blanco-Pillado, Arlington, MA (US); Francesco G. Salituro, Marlborough, MA (US); and Marshall Lee Morningstar, Framingham, MA (US)
Assigned to Sage Therapeutics, Inc., Cambridge, MA (US)
Filed by SAGE THERAPEUTICS, INC., Cambridge, MA (US)
Filed on Mar. 26, 2024, as Appl. No. 18/616,762.
Application 18/616,762 is a continuation of application No. 18/334,124, filed on Jun. 13, 2023, granted, now 11,970,514.
Application 18/334,124 is a continuation of application No. 17/311,056, abandoned, previously published as PCT/US2019/064692, filed on Dec. 5, 2019.
Claims priority of provisional application 62/775,470, filed on Dec. 5, 2018.
Prior Publication US 2024/0336648 A1, Oct. 10, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07J 43/00 (2006.01); C07J 41/00 (2006.01)
CPC C07J 43/003 (2013.01) [C07J 41/0044 (2013.01); C07J 41/0094 (2013.01)] 39 Claims
 
1. A compound selected from
 
Ex-
 
ample Structure
 
 
299
 

OG Complex Work Unit Chemistry
 
300
 

OG Complex Work Unit Chemistry
 
301
 

OG Complex Work Unit Chemistry
 
302
 

OG Complex Work Unit Chemistry
 
303
 

OG Complex Work Unit Chemistry
 
304
 

OG Complex Work Unit Chemistry
 
307
 

OG Complex Work Unit Chemistry
 
308
 

OG Complex Work Unit Chemistry
 
311
 

OG Complex Work Unit Chemistry
 
312
 

OG Complex Work Unit Chemistry
 
65
 

OG Complex Work Unit Chemistry
 
66
 

OG Complex Work Unit Chemistry
 
341
 

OG Complex Work Unit Chemistry
 
342
 

OG Complex Work Unit Chemistry
 
343
 

OG Complex Work Unit Chemistry
 
344
 

OG Complex Work Unit Chemistry
 
349
 

OG Complex Work Unit Chemistry
 
and
 
350
 

OG Complex Work Unit Chemistry